Clinical trial · Interventional
RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode
Radiofrequency Ablation Using Dual Cooled-Wet Electrode for Small Hepatocellular Carcinoma With No-touch Technique: Preliminary Study
NCT02806076CI-TRIAL-00050777unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to prospectively compare the clinical outcomes (local tumor progression rate, technical success rate, complication rate) of no touch radiofrequency ablation (RFA) technique for Hepatocellular carcinoma (HCC) to those of conventional tumor puncture RFA technique.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Hepatocellular | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Conventional tumor puncture RFA arm | Procedure | — | UNRESOLVED |
| No-touch RFA arm | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- No-touch RFA arm
- description
- No-touch RFA arm indicates RFA procedure without direct tumor puncture. In this study, RFA is done by using dual cooled electrode.
- interventionNames
- Procedure: No-touch RFA arm
- type
- ACTIVE_COMPARATOR
- label
- Conventional tumor puncture RFA arm
- description
- Conventional tumor puncture RFA arm indicates RFA procedure using "conventional tumor puncture" technique. In this study, RFA is done by using dual cooled electrode.
- interventionNames
- Procedure: Conventional tumor puncture RFA arm
Primary outcomes (1)
- measure
- 12 month local tumor progression (LTP) rate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Child-Pugh class A * patient with 1-2.5cm sized HCC * 1 or 2 HCC lesions Exclusion Criteria: * maximum tumor diameter greater than 2.5cm * Child-Pugh class B or C * more than 3 HCC lesions * invisible tumor even after US/CT or US/MR fusion * presence of vascular tumor thrombosis or extrahepatic metastasis * severe coagulopathy (PLT \< 50K, PT \< 50% of normal range)
References
Publications (0)
Data not yet available
No reference posted for this study.